[Research Report] “Awareness Survey on Reforming Existing Systems to Achieve Sustainable Antimicrobial Resistance (AMR) Countermeasures: Looking Beyond the COVID-19 Pandemic” Overall Results. (March 31, 2023)
date : 3/31/2023
Tags: AMR
![[Research Report] “Awareness Survey on Reforming Existing Systems to Achieve Sustainable Antimicrobial Resistance (AMR) Countermeasures: Looking Beyond the COVID-19 Pandemic” Overall Results. (March 31, 2023)](https://hgpi.org/en/wp-content/uploads/sites/2/amr-20230331-top_ENG.png)
In cooperation with seven academic societies related to infectious diseases (The Joint Review Committee of Seven Academic Societies for the Promotion of Infectious Disease Therapy and Drug Discovery and Japanese Association of Medical Technologists), AMR Alliance Japan (Secretariat: Health and Global Policy Institute) has conducted a survey on the awareness of drug development and testing within AMR countermeasures among members of the aforementioned societies, including physicians, pharmacists, and Medical Technologists. Overall results of this study are available below.
*Free-form responses and detailed reports will be published later.
[Survey Overview]
- Objectives: To clarify the gap between the awareness of the issue in the field and the related policy by identifying the attitudes of medical professionals (physicians, pharmacists and medical technologists) engaged in infectious disease care toward the Drug Development and Testing system.
- Research period: November 1, 2022 – November 14, 2022
- Subjects: Physicians/ Pharmacists/ Medical Technologists of eligible society officers and members
- Method: Email and website posting
- Number of responses: 391 (Physicians 72, Pharmacists 72, Medical Technologists 247)
日本語
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Establishing an Integrated Care System for Pain from the Perspectives of People with Lived Experience (March 29, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] Participation in an International Survey on Brain Health for Young People “The Next Generation (NextGen) Brain Health Research Program” (July 1, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Japanese Version Release] “Call for Actionable Steps in Response to the Rising Threat of Antimicrobial Resistance (AMR)” (July 3, 2024)
Featured Posts
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)
-
2024-07-17
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Towards Overcoming Kidney Disease: Strengthening Measures Against CKD” (June 7, 2024)
-
2024-07-18
[Registration Open] (Hybrid Format) Kidney Disease Control Promotion Project Public Symposium “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” (August 28, 2024)
-
2024-07-22
[HGPI Policy Column] No. 44 — From the Planetary Health Policy Project, Part 9 “Connecting Climate Minds: the Intersection of Climate Change and Mental Health”
-
2024-07-23
[Registration Open] (Webinar) HGPI Special Seminar “The Emerging Threat of Antifungal Resistance — Considering Infectious Diseases Caused by Mold and Measures to Combat Drug Resistance” (August 23, 2024)